BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7530971)

  • 1. Immune biological products: normal and specific immunoglobulin.
    Fara GM; Di Roma S
    Ann Ig; 1994; 6(1):3-12. PubMed ID: 7530971
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with the viral safety of immunoglobulins.
    Hellstern P
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 3():S31-4; discussion S35. PubMed ID: 7749046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of immune globulins.
    Tepper M; Gully P
    Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of intravenous immunoglobulins.
    Nydegger UE; Mohacsi PJ; Escher R; Morell A
    Vox Sang; 2000; 78 Suppl 2():191-5. PubMed ID: 10938951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
    Mehta YS; Badakere SS
    J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers.
    Hopkins RJ; Kramer WG; Blackwelder WC; Ashtekar M; Hague L; Winker-La Roche SD; Berezuk G; Smith D; Leese PT
    Clin Infect Dis; 2004 Sep; 39(6):759-66. PubMed ID: 15472804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and use of therapeutic antibodies primarily of human origin.
    Stiehm ER; Keller MA; Vyas GN
    Biologicals; 2008 Nov; 36(6):363-74. PubMed ID: 18789721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin therapy: methods of delivery.
    Ballow M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome.
    Leen WG; Weemaes CM; Verbeek MM; Willemsen MA; Rotteveel JJ
    Pediatr Neurol; 2008 Sep; 39(3):213-7. PubMed ID: 18725071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of immunoglobulins.
    Stiehm ER; Orange JS; Ballow M; Lehman H
    Adv Pediatr; 2010; 57(1):185-218. PubMed ID: 21056739
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical use of immunoglobulins].
    Nicodemo AC; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(1):46-52. PubMed ID: 1307403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvent/detergent treatment does not alter the tolerance or uptake of human normal immunoglobulin for intramuscular injection.
    Mould GP; Sutton JA; Matejtschuk P; Gascoigne EW; Dash CH
    Vox Sang; 2001 Apr; 80(3):151-8. PubMed ID: 11449954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic anemia following intravenous immunoglobulin administration.
    Yin F; Nesbitt JA; Tobian AA; Holt PA; Mikdashi J
    Am J Hematol; 2008 Oct; 83(10):825. PubMed ID: 18756544
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoglobulin therapy of primary humoral immunologic deficiencies].
    Bordigoni P
    Rev Prat; 2007 Oct; 57(15):1691-8. PubMed ID: 18080428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel aspects of hypogammaglobulinemic states: subcutaneous immunoglobulin treatment.
    Grunebaum E; Levy Y; Shoenfeld Y
    Isr Med Assoc J; 2002 Apr; 4(4):288-9. PubMed ID: 12001706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Viral safety considerations in immunoglobulin preparations].
    Gómez Manzano P; Escrivá CA; Salmerón García F; Alonso Verduras C
    Sangre (Barc); 1997 Jun; 42(3):199-203. PubMed ID: 9381262
    [No Abstract]   [Full Text] [Related]  

  • 17. Current perspectives on the use of intravenous immunoglobulin.
    Dickler HB; Gelfand EW
    Adv Intern Med; 1996; 41():641-80. PubMed ID: 8903601
    [No Abstract]   [Full Text] [Related]  

  • 18. The safety of intravenous immunoglobulin preparations.
    Weisman LE
    Isr J Med Sci; 1994; 30(5-6):459-63. PubMed ID: 8034504
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of intravenous immune globulin in multiple myeloma.
    Chapel HM; Lee M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):21-4. PubMed ID: 8033429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-antibiotic treatment of sepsis].
    Møller K; Kronborg G; Pedersen BK
    Ugeskr Laeger; 2000 May; 162(20):2872-5. PubMed ID: 10860425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.